An exaggerated headline from India Dailysuggests that this was the case, but the accompanying article does nothing to substantiate that claim. (A recent update on Ranbaxy's Pipeline also appeared in India's Business Standard.
An exaggerated headline from India Dailysuggests that this was the case, but the accompanying article does nothing to substantiate that claim. (A recent update on Ranbaxy's Pipeline also appeared in India's Business Standard.
